Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilding

Showing results (981-990 of 1,893) with videos related to

Pageof 190
Sort By:
European Journal of Clinical Investigation|October 8, 2008
Growth hormone and changes in energy balance in growth hormone deficient adultsD Deepak, C Daousi, E Boyland, et al.
International Journal of Clinical and Experimental Pathology|March 13, 2010
CD138 (Syndecan-1) in thymic tumors: correlation with various World Health Organization types and clinical outcomeOsama M Al-Agha, Weiguo Liu, Rameela Chandrasekhar, et al.
QJM : Monthly Journal of the Association of Physicians|October 21, 2003
Intensified treatment of type 2 diabetes--positive effects on blood pressure, but not glycaemic controlG V Gill, A Woodward, S Pradhan, et al.
BJU International|November 22, 2008
Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysisBertram Yuh, Zubair Butt, Anees Fazili, et al.
Cancer Research|August 17, 2002
Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) miceJenny Wilding, Josef Straub, Julie Bee, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Food fails to suppress ghrelin levels in obese humansP J English, M A Ghatei, I A Malik, et al.
Pharmaceutical Research|April 9, 2004
Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphyIan R Wilding, Alyson L Connor, Polly Carpenter, et al.
The Journal of Endocrinology|February 1, 1992
Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in ratsJ P Wilding, S G Gilbey, M Mannan, et al.
Journal of Child Neurology|September 24, 2014
X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 GeneColleen D'Arcy, Voula Kanellakis, Robin Forbes, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 2, 2020
Association of state vision screening requirements with parent-reported vision testing in young childrenJohn H Lillvis, Denise F Lillvis, Lorin M Towle-Miller, et al.
Pageof 190

Showing results (981-990 of 1,893) with videos related to

Sort By:
Pageof 190
European Journal of Clinical Investigation|October 8, 2008
Growth hormone and changes in energy balance in growth hormone deficient adultsD Deepak, C Daousi, E Boyland, et al.
International Journal of Clinical and Experimental Pathology|March 13, 2010
CD138 (Syndecan-1) in thymic tumors: correlation with various World Health Organization types and clinical outcomeOsama M Al-Agha, Weiguo Liu, Rameela Chandrasekhar, et al.
QJM : Monthly Journal of the Association of Physicians|October 21, 2003
Intensified treatment of type 2 diabetes--positive effects on blood pressure, but not glycaemic controlG V Gill, A Woodward, S Pradhan, et al.
BJU International|November 22, 2008
Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysisBertram Yuh, Zubair Butt, Anees Fazili, et al.
Cancer Research|August 17, 2002
Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) miceJenny Wilding, Josef Straub, Julie Bee, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Food fails to suppress ghrelin levels in obese humansP J English, M A Ghatei, I A Malik, et al.
Pharmaceutical Research|April 9, 2004
Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphyIan R Wilding, Alyson L Connor, Polly Carpenter, et al.
The Journal of Endocrinology|February 1, 1992
Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in ratsJ P Wilding, S G Gilbey, M Mannan, et al.
Journal of Child Neurology|September 24, 2014
X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 GeneColleen D'Arcy, Voula Kanellakis, Robin Forbes, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 2, 2020
Association of state vision screening requirements with parent-reported vision testing in young childrenJohn H Lillvis, Denise F Lillvis, Lorin M Towle-Miller, et al.
Pageof 190